WindRose Health Investors
Venture Capital and Private Equity PrincipalsNew York, United States11-50 Employees
WindRose Health Investors is a New York-based venture capital and private equity firm that makes private equity investments in healthcare services companies. The firm targets profitable healthcare services businesses with the ability to deliver cost-effective solutions. It operates with a team of 11 to 50 professionals and pursues new investments from its seventh fund, based at 375 Park Avenue, 28th Floor, New York, NY 10152. Recent activity includes the sale of Altruix to Frazier Healthcare Partners in May 2026 and the launch of WindRose Gradient to support portfolio company AI capabilities in April 2026. In March 2026, WindRose was recognized as a top 20 Upper MidMarket private equity firm by HEC-Dow Jones, reflecting its market presence.